Search

Search Constraints

You searched for: Author/Creator Otvos, Balint

Search Results

1. ATIM-40. CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS PREDICT FAVORABLE RESPONSE TO IMMUNE CHECKPOINT THERAPY IN A RANDOMIZED TRIAL OF NIVOLUMAB AND BEVACIZUMAB IN RECURRENT GBM. (11th November 2019)

2. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion. (27th May 2016)

3. Cancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression. (17th June 2014)

4. Cancer Stem Cell‐Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion. (27th May 2016)

5. Cancer Stem Cell‐Specific Scavenger Receptor 36 Drives Glioblastoma Progression. (July 2014)

6. Cancer Stem Cell‐Specific Scavenger Receptor CD36 Drives Glioblastoma Progression. (17th June 2014)

7. Combination Laser Interstitial Thermal Therapy Plus SRS Increases Time to Progression for Recurrent SRS-Treated Brain Metastases. (16th November 2020)

8. Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases. Issue 1 (2nd June 2022)

9. Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling. Issue 5 (15th September 2015)

10. Decreased Circulating Myeloid Derived Suppressor Cells at First Follow-up Predict Favorable Response to Immunotherapy in a Randomized Trial of Nivolumab and Bevacizumab in Recurrent GBM. (1st September 2019)